Health Level Seven International (HL7) and AEGIS.net (AEGIS) recently announced the launch of a new Conformance Testing Program for HL7 standards. The HL7 Conformance Testing Program provides a platform for ongoing, iterative testing that helps HIT developers get highly interoperable products to market quickly and cost-effectively. The testing program will make interoperability significantly more efficient for vendors as well as implementers by reducing interface development time and costs.
“We chose to partner with AEGIS because they’re an industry leader in the testing of interoperability between health information technology systems and HIEs,” says Charles Jaffe, MD, PhD, CEO of HL7 International. “Going forward, HL7 anticipates using the AEGIS Developers Integration Lab to provide a testing platform for both existing and new HL7 standards.”
The Conformance Testing Program leverages the technology and architecture of the AEGIS Developers Integration Lab (DIL). The DIL is an infrastructure-as-a-service and testing-as-a-service open source testing solution for health information exchange gateway, interoperability, and compatibility testing.The DIL helps automate and execute test cases created by HL7, providing an easy-to-use system for ongoing, iterative, 24/7/365 conformance and interoperability tests against published HL7 specifications.
Mario Hyland, senior vice president of AEGIS says, “AEGIS is proud to partner with HL7 International to bring its members a unique benefit offering HL7-specific conformance testing for continuous interoperability through the AEGIS DIL.”
The program is currently in a pilot phase, during which supported standards are limited to Version 2 Immunization Registries. Participation will be free of charge until the HL7 Working Group Meeting in September 2014.
Source: Health Level Seven International